Members
- Leif Bjermer - Lead
- Zuzana Diamant
- Helgo Magnussen
- Giorgio Piacentini
- Joaquin Sastre
- Nicolas Roche
- Ian Pavord
- Kjell Alving
- Omar Usmani
- Victoria Carter
- Akio Niimi
- Francine Ducharme
- Andrei Malinovschi
- Nikos Papadopoulos
- Salman Saddiqui
- Ted Popov
- George Christof
- Paschalis Steiropoulos
- Ron Dandurand
- Radek Gawlik
Work Plan
The Biomarkers & Severe Asthma Working Group examine the role of biomarkers as a predictive measure to inform improved patient care and suggest opportunities to update future clinical practice guidelines to reflect their value, alongside examining the increasingly vital issue of severe asthma. The group is currently particularly interested in the value of FeNO in predicting outcomes and improving management in obstructive lung disease.